-
Order Details
1
-
Confirm
2
Article Details
- Journal Title
- Advances in Hematology
- Volume
- 2022
- Article Title
- Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576
- List of Authors
-
- Paula A. Lengerke-Diaz(ORCID ID: https://orcid.org/0000-0002-1285-8499)
- Juliana Velez Lujan
- Michael Y. Choi(ORCID ID: https://orcid.org/0000-0002-9107-2186)
- Eider F. Moreno-Cortes(ORCID ID: https://orcid.org/0000-0001-7629-6264)
- Jose V. Forero(ORCID ID: https://orcid.org/0000-0001-9872-5760)
- Juan Esteban Garcia-Robledo(ORCID ID: https://orcid.org/0000-0003-2912-152X)
- Chaja Jacobs(ORCID ID: https://orcid.org/0000-0002-7294-4364)
- Colin McCarthy
- Alaina Heinen
- Carlos I. Amaya-Chanaga
- Thomas J. Kipps(ORCID ID: https://orcid.org/0000-0002-0064-4549)
- Article ID
- 4450824
- Article Type
- Research Article
- No. of Pages
- 8 Pages
- Additional Authors
Invoice Details
- Invoice Issue Date
- 8 June 2023
- Type of Reprints
- Colored, Covered
- Invoice Ref. No.
- Terms
- Payable upon Receipt
Charges
- No. of Copies
- Reprints Charges
- 0.00
- Total
- $